NPR interviews Devan Kansagara, M.D., about large gaps in evidence regarding the connection between cannabis and mental health. He says, “What we wanted to do is convey that cannabis is not one thing because it’s such a complex substance.”

18,000 people participated in this year’s Shamrock Rock, which benefits the Child Life Program at Doernbecher.

Kevin Duff, Ph.D., discusses how early detection recommendations for Alzheimer’s have changed over recent years, and with the emergence of new drugs, many early-stage patients can experience dramatically improved outcomes.

KOIN-TV reports on an infant receiving treatment in Doernbecher’s Pediatric Intensive Care Unit for a rare heart defect and a rare genetic disorder that affects growth and development.

A new study led by Obert Xu, M.B.B.S., describes how OHSU’s ED was able to improve CT report turnaround times amid an increase in imaging demand. Xu and her coauthors say: “Emergency departments across the United States are facing unprecedented patient volumes and overcrowding, amplifying the need to optimize throughput and operational efficiency. CT turnaround time is the interval from imaging order to interpretation, and this represents a key determinant of ED flow. Our objective was to reduce the interval between preliminary resident interpretation and teleradiology service request by 25% through targeted workflow redesign and implementation of iterative quality improvement interventions.”

OncoDaily shares photos of the new Vista Pavilion, Flavia Rocha, M.D., and colleagues in its “Voices” column.

Continued coverage of a secret shopper-style survey of four cities led by OHSU that finds barely one-third of the Portland clinics accept new Medicare patients. Jane Zhu, M.D., says: “Primary care is the front door to the health care system, connecting patients to chronic disease management, preventive health and long-term coordinated care to avoid costly hospitalizations and emergency room visits. The opposite is also true: Consistent access to primary care is associated with better health outcomes and lower overall costs.”

Report on a debate among clinicians about whether to prescribe an unproven autism drug, and OHSU is mentioned as having issued guidance to its clinicians not to prescribe the drug until more research on its safety and effectiveness is released.

Report on a debate among clinicians about whether to prescribe an unproven autism drug, and OHSU is mentioned as having issued guidance to its clinicians not to prescribe the drug until more research on its safety and effectiveness is released.

Sue Aicher, Ph.D., and Brooke Harkness, O.D., are among a panel of national experts invited on The Pain Beat podcast to discuss the different types and distinct mechanisms driving eye pain.